222 related articles for article (PubMed ID: 12904684)
1. Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients.
el-Agroudy AE; Hassan NA; Foda MA; Ismail AM; el-Sawy EA; Mousa O; Ghoneim MA
Am J Nephrol; 2003; 23(5):300-6. PubMed ID: 12904684
[TBL] [Abstract][Full Text] [Related]
2. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.
Campistol JM; Iñigo P; Jimenez W; Lario S; Clesca PH; Oppenheimer F; Rivera F
Kidney Int; 1999 Aug; 56(2):714-9. PubMed ID: 10432413
[TBL] [Abstract][Full Text] [Related]
3. Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.
Praga M; Andrade CF; Luño J; Arias M; Poveda R; Mora J; Prat MV; Rivera F; Galceran JM; Ara JM; Aguirre R; Bernis C; Marín R; Campistol JM
Nephrol Dial Transplant; 2003 Sep; 18(9):1806-13. PubMed ID: 12937228
[TBL] [Abstract][Full Text] [Related]
4. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.
Iñigo P; Campistol JM; Lario S; Piera C; Campos B; Bescós M; Oppenheimer F; Rivera F
J Am Soc Nephrol; 2001 Apr; 12(4):822-827. PubMed ID: 11274244
[TBL] [Abstract][Full Text] [Related]
5. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
Park HC; Xu ZG; Choi S; Goo YS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
Nephrol Dial Transplant; 2003 Jun; 18(6):1115-21. PubMed ID: 12748343
[TBL] [Abstract][Full Text] [Related]
6. Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy.
Campistol JM; Iñigo P; Larios S; Bescos M; Oppenheimer F
Nephrol Dial Transplant; 2001; 16 Suppl 1():114-6. PubMed ID: 11369837
[TBL] [Abstract][Full Text] [Related]
7. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Profibrotic Gene Expression by Angiotensin Receptor Blockers.
Nafar M; Samavat S; Shahraki E
Iran J Kidney Dis; 2018 Nov; 12(6):369-375. PubMed ID: 30595567
[TBL] [Abstract][Full Text] [Related]
9. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
10. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
Wu SC; Liu CP; Chiang HT; Lin SL
Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation.
Holgado R; Anaya F; Del Castillo D
Nephrol Dial Transplant; 2001; 16 Suppl 1():117-20. PubMed ID: 11369838
[TBL] [Abstract][Full Text] [Related]
13. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
Schmidt A; Gruber U; Böhmig G; Köller E; Mayer G
Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenetics of angiotensin system in non diabetic nephropathy].
Coto E; Marín R; Alvarez V; Praga M; Fernández Andrade C; Arias M; Poveda R; Vallés M; Galcerán JM; Luño J; Rivera F; Campistol JM
Nefrologia; 2005; 25(4):381-6. PubMed ID: 16231503
[TBL] [Abstract][Full Text] [Related]
15. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
16. Anti-hypertensive strategies in patients with MEtabolic parameters, DIabetes mellitus and/or NephropAthy (the M E D I N A study).
Spinar J; Vitovec J; Soucek M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):412-21. PubMed ID: 24026142
[TBL] [Abstract][Full Text] [Related]
17. [Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)].
Shibasaki Y; Nishiue T; Masaki H; Matsubara H; Iwasaka T
Nihon Rinsho; 2002 Oct; 60(10):1992-8. PubMed ID: 12397697
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, controlled study of losartan in children with proteinuria.
Webb NJ; Lam C; Loeys T; Shahinfar S; Strehlau J; Wells TG; Santoro E; Manas D; Gleim GW
Clin J Am Soc Nephrol; 2010 Mar; 5(3):417-24. PubMed ID: 20089489
[TBL] [Abstract][Full Text] [Related]
19. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
[TBL] [Abstract][Full Text] [Related]
20. Effect of losartan on slowing progression of chronic allograft nephropathy.
Wang PX; Fan MQ; Huang CB; Feng JY; Xiao Y; Fang ZQ; Zhang YP
Chin Med Sci J; 2005 Dec; 20(4):231-6. PubMed ID: 16422249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
